TRPV4 and melanocytic nevus: We compared TRPV4 expression in sweat glands from patients with melanocytic nevus (n = 10, ages; 15–63) as controls and patients with AIGA (n = 10, ages; 24–55) using a commercially available anti-TRPV4 antibody different from the one utilized in the mouse samples.